FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281786798> ?p ?o ?g. }

• W4281786798 endingPage "e18624" @default.
• W4281786798 startingPage "e18624" @default.
• W4281786798 abstract "e18624 Background: Four in 10 people aged 60-69 have hearing loss in frequencies that mediate speech comprehension. Untreated losses undermine medication adherence, increase risk for accidental injury, and generate higher total healthcare expenditures. Genitourinary (GU) malignancies are most frequently diagnosed in people over 60, and these patients are commonly exposed to ototoxic treatments like platinum-based chemotherapy. We hypothesized that a significant number of GU patients would fail hearing screenings at levels reflecting clinically significant hearing loss. Methods: This is a prospective, two-cohort pilot study conducted at Tulane Medical Center. Consecutive patients with active GU malignancies who did not use hearing aids were enrolled in cohort A. The primary objective of cohort A (screening) was to determine the prevalence of hearing loss among GU patients. Cohort B (interventional) will investigate the efficacy of a non-custom amplifier in improving communication for patients with hearing loss. The hearing screening consisted of a 9-item Self-Assessment of Communication (SAC) and a 25 decibel (dB) pure tone hearing screening at 1 kHz, 2 kHz, 4 kHz via an Earscan3 portable audiometer with headphones in a quiet exam room. The primary endpoint was the proportion of patients who failed the hearing screening (missed ≥ 2/6 tones). The SAC generates a global handicap score (none, slight, mild-to-moderate, severe). Surveys identifying any amount of handicap were considered positive. Patients who failed screenings were offered referrals to audiology. Here, we present results from cohort A. Results: From 8/21 to 1/22, 66 patients were invited to participate. Nine patients screen-failed (n = 8 hearing aids; n = 1 uninterested). Cohort A enrolled 57 patients [median age 68 (33-86); 91% men; 60% prostate, 24% kidney and 14% bladder cancer]. Most patients (82%) had evidence of metastatic disease and 12%, 19%, 36%, 21% of patients were receiving chemotherapy, immunotherapy, hormonal therapy, and no active therapy, respectively. Twenty (35%) patients had prior exposure to neurotoxic chemotherapy. Forty patients (70%) met the primary endpoint. Compared to the pure tone screening, the SAC had a specificity of 94%, and a sensitivity of 40%. The SAC asks patients for a situation where they want to hear better; 61% of patients who volunteered a scenario (17/28) identified a complex listening environment like an outpatient encounter. A minority of patients (n = 3) accepted audiology referrals after failing screenings. Cohort B is actively enrolling. Conclusions: Clinically significant hearing loss was prevalent among patients with GU malignancies. Patients reported struggling in listening situations with auditory demands like outpatient encounters but were unable to self-identify losses and did not pursue audiology referrals after failed screenings. Interventional studies addressing this unmet need are warranted." @default.
• W4281786798 created "2022-06-13" @default.
• W4281786798 creator A5002020225 @default.
• W4281786798 creator A5016658303 @default.
• W4281786798 creator A5018399405 @default.
• W4281786798 creator A5020137267 @default.
• W4281786798 creator A5020584199 @default.
• W4281786798 creator A5032260428 @default.
• W4281786798 creator A5035682591 @default.
• W4281786798 creator A5041207788 @default.
• W4281786798 creator A5047780344 @default.
• W4281786798 creator A5053588971 @default.
• W4281786798 creator A5060092579 @default.
• W4281786798 creator A5077703073 @default.
• W4281786798 creator A5079534341 @default.
• W4281786798 creator A5089983989 @default.
• W4281786798 date "2022-06-01" @default.
• W4281786798 modified "2023-09-23" @default.
• W4281786798 title "Screening detects clinically significant hearing loss in patients with GU malignancies." @default.
• W4281786798 doi "https://doi.org/10.1200/jco.2022.40.16_suppl.e18624" @default.
• W4281786798 hasPublicationYear "2022" @default.
• W4281786798 type Work @default.
• W4281786798 citedByCount "0" @default.
• W4281786798 crossrefType "journal-article" @default.
• W4281786798 hasAuthorship W4281786798A5002020225 @default.
• W4281786798 hasAuthorship W4281786798A5016658303 @default.
• W4281786798 hasAuthorship W4281786798A5018399405 @default.
• W4281786798 hasAuthorship W4281786798A5020137267 @default.
• W4281786798 hasAuthorship W4281786798A5020584199 @default.
• W4281786798 hasAuthorship W4281786798A5032260428 @default.
• W4281786798 hasAuthorship W4281786798A5035682591 @default.
• W4281786798 hasAuthorship W4281786798A5041207788 @default.
• W4281786798 hasAuthorship W4281786798A5047780344 @default.
• W4281786798 hasAuthorship W4281786798A5053588971 @default.
• W4281786798 hasAuthorship W4281786798A5060092579 @default.
• W4281786798 hasAuthorship W4281786798A5077703073 @default.
• W4281786798 hasAuthorship W4281786798A5079534341 @default.
• W4281786798 hasAuthorship W4281786798A5089983989 @default.
• W4281786798 hasConcept C126322002 @default.
• W4281786798 hasConcept C141071460 @default.
• W4281786798 hasConcept C188816634 @default.
• W4281786798 hasConcept C204358264 @default.
• W4281786798 hasConcept C2779398211 @default.
• W4281786798 hasConcept C2780493683 @default.
• W4281786798 hasConcept C2780554537 @default.
• W4281786798 hasConcept C2781383708 @default.
• W4281786798 hasConcept C548259974 @default.
• W4281786798 hasConcept C71924100 @default.
• W4281786798 hasConcept C72563966 @default.
• W4281786798 hasConceptScore W4281786798C126322002 @default.
• W4281786798 hasConceptScore W4281786798C141071460 @default.
• W4281786798 hasConceptScore W4281786798C188816634 @default.
• W4281786798 hasConceptScore W4281786798C204358264 @default.
• W4281786798 hasConceptScore W4281786798C2779398211 @default.
• W4281786798 hasConceptScore W4281786798C2780493683 @default.
• W4281786798 hasConceptScore W4281786798C2780554537 @default.
• W4281786798 hasConceptScore W4281786798C2781383708 @default.
• W4281786798 hasConceptScore W4281786798C548259974 @default.
• W4281786798 hasConceptScore W4281786798C71924100 @default.
• W4281786798 hasConceptScore W4281786798C72563966 @default.
• W4281786798 hasIssue "16_suppl" @default.
• W4281786798 hasLocation W42817867981 @default.
• W4281786798 hasOpenAccess W4281786798 @default.
• W4281786798 hasPrimaryLocation W42817867981 @default.
• W4281786798 hasRelatedWork W1883906525 @default.
• W4281786798 hasRelatedWork W1981668649 @default.
• W4281786798 hasRelatedWork W2086034128 @default.
• W4281786798 hasRelatedWork W2099623915 @default.
• W4281786798 hasRelatedWork W2102629691 @default.
• W4281786798 hasRelatedWork W2409654149 @default.
• W4281786798 hasRelatedWork W2811316669 @default.
• W4281786798 hasRelatedWork W2952005003 @default.
• W4281786798 hasRelatedWork W3162180531 @default.
• W4281786798 hasRelatedWork W4281786798 @default.
• W4281786798 hasVolume "40" @default.
• W4281786798 isParatext "false" @default.
• W4281786798 isRetracted "false" @default.
• W4281786798 workType "article" @default.